Results
1 -
10 of
22Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis, BMC Cancer Die Tyrosinkinasen-Inhibitoren Imatinib (Glivec) und NVP-AEE788 und der mTOR-Inhibitor Sirolimus hemmen das Wachstum von Gallengangskarzinomen in vitro und in vivo, Chirurgisches Forum 2006 Inhibition of Growth Factor Signaling by Small-Molecule Inhibitors of ErbB, Raf,and MEK, Cancer Role of Pericytes in Resistance to Antiangiogenic Therapy, The Tumor Microenvironment Beyond Trastuzumab: Second-Generation Targeted Therapies for HER-2-positive Breast Cancer, Drugs for HER-2-positive Breast Cancer Host?Tumor Interactions in Brain Cancer Metastasis Leading to Drug Resistance, Resistance to Targeted Therapies Against Adult Brain Cancers Anti-VEGF Strategies in Ocular Angiogenesis-mediated Disorders, with Special Emphasis on Age-related Macular Degeneration, Angiogenesis Modulations in Health and Disease Pr??klinische Studien zum Einfluss des Tyrosinkinaseinhibitors AEE788 auf die Malignit??t des Nierenzellkarzinoms, Der Urologe Pharmacokinetic drug interaction between AEE788 and RAD001 causing thrombocytopenia in patients with glioblastoma, Cancer Chemotherapy and Pharmacology